Publications by authors named "Monno L"

The aims of this study were to characterize new SARS-CoV-2 genomes sampled all over Italy and to reconstruct the origin and the evolutionary dynamics in Italy and Europe between February and June 2020. The cluster analysis showed only small clusters including < 80 Italian isolates, while most of the Italian strains were intermixed in the whole tree. Pure Italian clusters were observed mainly after the lockdown and distancing measures were adopted.

View Article and Find Full Text PDF
Article Synopsis
  • The number of patients at risk for Candida bloodstream infections (CBSI) is increasing in modern medicine, with a median of 77 CBSI cases per year recorded in one hospital from 2015 to 2018.
  • A notable rise in CBSI caused by C. albicans was observed, growing from 65% to 71% in medical wards, alongside an alarming increase in antifungal resistance, particularly in C. guillermondii and fluconazole resistance.
  • The study highlights the urgent need for antifungal stewardship programs to combat the rapid spread of antifungal resistance in the hospital setting.
View Article and Find Full Text PDF

Background: Immune checkpoint inhibitors (ICIs) have revolutionized nonsmall cell lung cancer (NSCLC) treatment and significantly increased overall survival of patients. However, the incidence of concurrent infections and their management is still debated.

Methods: From August 2015 to October 2019, all consecutive patients with NSCLC who received nivolumab or pembrolizumab as first- or second-line therapy were retrospectively evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how resistance-associated substitutions (RASs) impact the effectiveness of direct-acting antivirals (DAAs) in treating chronic hepatitis C virus (HCV) in Italy from 2015 to 2019.
  • It analyzes the prevalence and characteristics of various RASs in patients who failed DAA treatments, revealing a significant decline in NS5A and NS3/4A RAS prevalence, while NS5B RAS remained stable over the years.
  • The findings suggest that identifying RASs can improve future treatment strategies, with over 95% of cases still showing some susceptibility to certain DAA combinations.
View Article and Find Full Text PDF

Background: The spectrum of COVID-19 clinical manifestations is not yet known. In the elderly, mortality and extrapulmonary involvement appears more frequent than expected.

Methods: A multicentre-retrospective-case-series study of COVID-19 patients, aged ≥65 years, hospitalised between March 1 and June 15, 2020.

View Article and Find Full Text PDF

Data regarding the immunological memory and long-time kinetics of immunoglobulin (IgG) against viral nucleoprotein (NP) and spike protein S1 receptor-binding domain (S1RBD) of Severe Acute Respiratory Syndrome-associated Coronavirus 2 (SARS-CoV-2) are lacking. All consecutive COVID-19 patients admitted to our Clinic between March 1, 2020, and May 1, 2020, who were tested at hospital admission for anti-S1RBD and anti-NP IgG were enrolled. Serum samples were tested for anti-SARS-CoV-2 antibodies with the use of two commercially available enzyme-linked immunosorbent assays.

View Article and Find Full Text PDF

Introduction: Sexual and reproductive health (SRH) and Human Immunodeficiency Virus (HIV) are crucial global health issues. Uganda continues to sustain a huge burden of HIV and AIDS.

Methods: A cross-sectional health facility-based assessment was performed in November and December 2016 in Karamoja Region, northern Uganda.

View Article and Find Full Text PDF

Introduction: Cefiderocol is a new siderophore cephalosporin designed to be active against extensively resistant Gram-negative bacteria; however, clinical studies are limited to complicated urinary tract infections, pneumonia, and intra-abdominal infections. To date, no data are available on neurosurgical site infections.

Case Presentation: We present a case of a patient successfully cured with Cefiderocol for a neurosurgical site infection due to extensively resistant , who had failed a previous treatment based on combined antimicrobial therapy and right parietal bone excision.

View Article and Find Full Text PDF

The loss of patients to follow up is a major issue related to HIV management. Our research was aimed to evaluate, in a single Italian centre, the rate of patients lost to follow-up (LFU) over 10 years, to describe their socio-demographic and clinical features, and to identify predictors of disengagement from care. Between 2008 and 2017, 563 subjects were LFU.

View Article and Find Full Text PDF

Little is known about long-term maintenance of virologic suppression in HIV migrants in Italy. The study aims to compare virologic failure rates and associated factors among antiretroviral therapy (ART)-naïve migrants and natives enrolled in the ARCA database since 2007 who achieved virologic suppression within 18 months from the beginning of the ART. Kaplan-Meier method assessed the probability of virologic suppression and failure.

View Article and Find Full Text PDF

HIV-1 V2 domain binds α4β7, which assists lymphocyte homing to gut-associated lymphoid tissue. This triggers bacterial translocation, thus contributing to immune activation. We investigated whether variability of V2 binding site could influence plasma levels of lipopolysaccharide (LPS) and soluble cluster of differentiation 14 (sCD14), markers of microbial translocation/immune activation.

View Article and Find Full Text PDF

An autochthonous case of lymphocutaneous sporotrichosis caused by Sporothrix schenckii is reported. The patient developed skin lesions localized along the lymphatics that appeared after he suffered an injury while collecting wicker canes in marshy water. The fungus was identified as Sporothrix schenckii by MALDI-TOF and sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • Targeted therapies (TT) for autoimmune/idiopathic diseases have changed patient management but carry risks of adverse events, particularly opportunistic infections (OIs).
  • The relationship between TT and the risk of OIs is complex and not fully understood, with post-marketing reports indicating severe infections not seen in clinical trials.
  • The authors recommend structured clinical management involving multiple medical specialties to better prevent and treat TT-related infections in immunocompromised patients.
View Article and Find Full Text PDF

Objectives: Fostemsavir, a novel attachment inhibitor targeting the HIV-1 gp120, has demonstrated wide in vitro activity. However, the high rate of HIV gp120 substitutions could jeopardize its efficacy. We investigated envelope (env) substitutions at positions associated with resistance to fostemsavir in patients with a new HIV-1 diagnosis according to HIV subtype and tropism.

View Article and Find Full Text PDF

Background: Few data are available regarding the use of direct antiviral agents (DAAs) for chronic hepatitis C in psychiatric patients. The aim of the study is to assess safety and outcome of DAAs in patients with psychiatric comorbidities.

Methods: This retrospective, observational, single-centre study enrolled patients treated with psychiatric drugs who initiated DAAs between 2015 and 2018.

View Article and Find Full Text PDF

Background: An increase in pretreatment drug resistance (PDR) to first-line antiretroviral therapy (ART) in low-income countries has been recently described. Herein we analyse the prevalence of PDR and risk of virological failure (VF) over time among migrants to Italy enrolled in ARCA.

Methods: HIV-1 sequences from ART-naive patients of non-Italian nationality were retrieved from ARCA database from 1998 to 2017.

View Article and Find Full Text PDF

Sierra Leone is the country with highest maternal mortality and infections are the underlying cause in 11% of maternal deaths, but the real burden remains unknown. This study aims to determine the incidence and risk factors of surgical site infection (SSI) post-caesarean section (CS) in women admitted to Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone. A prospective case-control (1:3 ratio) study was implemented from 1 May 2018 to 30 April 2019 and 11 women presenting with suspected or confirmed infection post-CS were screened for inclusion as a case.

View Article and Find Full Text PDF
Article Synopsis
  • More than 87% of these individuals were on antiretroviral therapy, but 26.6% were still experiencing viral load (viremic) issues, with a significant proportion also dealing with hepatitis and tuberculosis.
  • Phylogenetic analysis revealed diverse HIV clades, particularly a high presence of Circulating Recombinant Forms, alongside alarming rates of drug resistance in both treated and untreated individuals, emphasizing the need for targeted public health measures.
View Article and Find Full Text PDF

4,000 new HIV diagnoses and approximately 800 AIDS cases are still reported annually in Italy. Improving public awareness and bringing out HIV-undiagnosed individuals are keystones to progress towards the control of the HIV epidemic. For this purpose, the Open HIV TEST project was organized and delivered by the Italian NGO Anlaids, together with local infectious diseases specialists, in order to provide free access to HIV testing outside the healthcare setting.

View Article and Find Full Text PDF

The accumulation of drug-resistance mutations on combined antiretroviral regimens (ART) backbone could affect the virological efficacy of the regimen. Our aim was to assess the impact of previous drug resistance to nucleoside reverse transcriptase inhibitors (NRTIs) on the probability of virological failure (VF) in patients, under virological control, who switched to dolutegravir (DTG)+2NRTIs regimens. All HIV-1 positive drug-experienced patients who started a regimen composed by DTG+2NRTIs [abacavir/lamivudine or tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF)/emtricitabine (FTC)] in the ARCA collaborative group with HIV-RNA <50 cp/mL were included in the analysis.

View Article and Find Full Text PDF

Human dirofilariosis is a zoonosis caused by different Dirofilaria species: D. repens, D. immitis, D.

View Article and Find Full Text PDF

The HIV V2 (HXB2 numbering) tripeptide mediates binding to α4β7 integrin, which is responsible for GALT homing. Our study aimed to assess V2 variability in naive HIV-1 infected patients and its association with clinical and viro-immunological features. Gp120 sequences were obtained from 322 subjects; length, potential N-linked glycosylation sites (PNGs), net-charge (NC) and tripeptide α4β7-binding-motif of V2 were evaluated.

View Article and Find Full Text PDF